Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 90,000 CLDX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 90,000 | n/a |
| May 1, 2026 | Altimmune, Inc. (ALT) | Grant/Award | 48,800 | n/a |
| Nov 12, 2025 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 100,000 | n/a |
| Sep 29, 2025 | Altimmune, Inc. (ALT) | Grant/Award | 48,800 | n/a |
| Feb 26, 2025 | Altimmune, Inc. (ALT) | Grant/Award | 69,800 | n/a |
| Mar 14, 2024 | DEXCOM INC (DXCM) | Sale | 4,764 | $640.3K |
| Mar 11, 2024 | DEXCOM INC (DXCM) | Grant/Award | 26,053 | n/a |
| Mar 10, 2023 | DEXCOM INC (DXCM) | Grant/Award | 45,352 | $45.35 |